BioSpace News Archive

Juvenescence Ltd, a biopharmaceutical company focused on treating aging and age-related disease, is pleased to announce its latest equity investment in BYOMass Inc., a Massachusetts-based company focused on central control of metabolism in the context of aging and age-related diseases.

Movement Orthopedics in Clinton Township, MI uses injections to ease your joint pain and restore its function

Endoceutics Inc., Université Laval, and CHU de Québec-Université Laval are pleased to announce that they have reached an agreement to resolve all their disputes with respect to economic benefits deriving from research.

Inovio Pharmaceuticals, Inc. announced that management will present at the H.C. Wainwright Global Life Sciences Conference on Monday, April 8, 2019 at 4:10 p.m. local time.

Cirius Therapeutics, a clinical stage pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and metabolic diseases, announced today that it will present preclinical data supporting the importance of the unique mechanism of action of its lead drug candidate for NASH at The International Liver Congress

Chargers wide receiver Geremy Davis, running back Justin Jackson and the Charger Girls to meet the students and support necessary cause

Tap Native, the Web’s leading health focused native ad platform and traffic exchange, has announced the exit of its beta status and the official launch of its health only traffic exchange designed for health, wellness and medical publishers.

Urovant Sciences (Nasdaq: UROV), a clinical-stage biopharmaceutical company developing and commercializing innovative therapies for urologic conditions, today announced that it has initiated COURAGE, an international Phase 3 trial to evaluate the safety and efficacy of vibegron for symptoms of overactive bladder (OAB) in men who are receiving pharmacological treatment for benign prostatic hyperplasia (BPH).

Potential to target GPRC5D in multiple myeloma patients relapsed after BCMA-targeted therapy

From the devastating impact of crime on families and cities, lost productivity, costs to employers and the economy, to staggering health care costs raising premiums and taxes, the impact of addiction in America amounts to $1.45 trillion dollars each year, a study newly released by Recovery Centers of America (RCA) shows.